NuCana plc

The momentum for this stock is not very good. NuCana plc is not a good value stock. NuCana plc is not a good growth stock. NuCana plc is not very popular among insiders. NuCana plc is a mediocre stock to choose.

NuCana Plc engages in the development of technology platform for the treatment of patients with canc...

News

NuCana (NASDAQ:NCNA) PT Lowered to $25.00 at Oppenheimer

Zolmax NuCana (NASDAQ:NCNA - Get Free Report) had its target price lowered by equities researchers at Oppenheimer from $150.00 to $25.00 in a research report issued on Tuesday, Benzinga reports. The firm...\n more…

NuCana (NASDAQ:NCNA) Price Target Lowered to $25.00 at Oppenheimer

Ticker Report NuCana (NASDAQ:NCNA - Free Report) had its price objective decreased by Oppenheimer from $150.00 to $25.00 in a research report released on Tuesday morning, Benzinga reports. Oppenheimer currently...\n more…

NuCana (NASDAQ:NCNA) Downgraded to Market Perform at William Blair

Ticker Report William Blair downgraded shares of NuCana (NASDAQ:NCNA - Free Report) from an outperform rating to a market perform rating in a report released on Friday morning, MarketBeat reports. Separately...\n more…

NuCana plunges after trial setback for cancer drug

Seeking Alpha - Healthcare NuCana plunges after trial setback for cancer drug...\n more…

NuCana PLC (ADR) trading resumes

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…